Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksSerinus Energy Regulatory News (SENX)

Share Price Information for Serinus Energy (SENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.30
Ask: 3.70
Change: 0.00 (0.00%)
Spread: 0.40 (12.121%)
Open: 3.50
High: 3.78
Low: 3.50
Prev. Close: 3.50

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 Annual Results Investor Presentation

11 Mar 2024 07:00

RNS Number : 2133G
Serinus Energy PLC
11 March 2024
 

11 March 2024

 

Press Release

2023 Annual Results Investor Presentation

Jersey, Channel Islands, 11 March 2024 -- Serinus Energy plc ("Serinus" or the "Company") (AIM:SENX, WSE:SEN) is pleased to announce that Jeffrey Auld (CEO), Vlad Ryabov (CFO), Stuart Morrison (COO), and Calvin Brackman (VP, External Relations & Strategy) will provide a live presentation relating to the 2023 Annual Financial Results via the Investor Meet Company platform on 18 March 2024 at 10:00am GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet SERINUS ENERGY PLC via:

https://www.investormeetcompany.com/serinus-energy-plc/register-investor

Investors who already follow SERINUS ENERGY PLC on the Investor Meet Company platform will automatically be invited.

About Serinus

Serinus is an international upstream oil and gas exploration and production company that owns and operates projects in Tunisia and Romania.

For further information, please refer to the Serinus website (www.serinusenergy.com) or contact the following:

 

Serinus Energy plc

Jeffrey Auld, Chief Executive Officer

Calvin Brackman, Vice President, External Relations & Strategy

+44 204 541 7859

Shore Capital (Nominated Adviser & Broker)

Toby Gibbs

Lucy Bowden

 

+44 207 408 4090

 

Forward Looking Statement Disclaimer

This release may contain forward-looking statements made as of the date of this announcement with respect to future activities that either are not or may not be historical facts. Although the Company believes that its expectations reflected in the forward-looking statements are reasonable as of the date hereof, any potential results suggested by such statements involve risk and uncertainties and no assurance can be given that actual results will be consistent with these forward-looking statements. Various factors that could impair or prevent the Company from completing the expected activities on its projects include that the Company's projects experience technical and mechanical problems, there are changes in product prices, failure to obtain regulatory approvals, the state of the national or international monetary, oil and gas, financial , political and economic markets in the jurisdictions where the Company operates and other risks not anticipated by the Company or disclosed in the Company's published material. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties, and actual results may vary materially from those expressed in the forward-looking statement. The Company undertakes no obligation to revise or update any forward-looking statements in this announcement to reflect events or circumstances after the date of this announcement, unless required by law.

 

Translation: This news release has been translated into Polish from the English original.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEASDPEAXLEFA
Date   Source Headline
10th Oct 20247:00 amRNSHolding(s) in Company
3rd Oct 20247:00 amRNSHolding(s) in Company
19th Sep 20247:00 amRNSHolding(s) in Company
11th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20247:00 amRNSHolding(s) in Company
2nd Sep 20247:00 amRNSHolding(s) in Company
12th Aug 20247:00 amRNSHolding(s) in Company
12th Aug 20247:00 amRNSH1 2024 Financial Results
5th Aug 20247:00 amRNSH1 2024 Results Investor Presentation
2nd Jul 20247:00 amRNSDirector Resignation
27th Jun 20247:00 amRNSDirector/PDMR Shareholding
12th Jun 20247:00 amRNSHolding(s) in Company
6th Jun 20247:00 amRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSDirector/PDMR Shareholding
14th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSQ1 2024 Financial Results
10th May 20243:32 pmRNSAGM Voting Results
7th May 20247:00 amRNSQ1 2024 Results Investor Presentation
18th Apr 20247:00 amRNSNotice of Annual General Meeting
11th Mar 20247:00 amRNS2023 Annual Results Investor Presentation
20th Feb 20246:31 pmRNSHolding(s) in Company
26th Jan 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSParticipation in Onshore Angola Licence Round
3rd Jan 20247:00 amRNSHolding(s) in Company
27th Nov 20237:00 amRNSQ3 2023 Results
20th Nov 20237:00 amRNSInvestor Presentation
10th Nov 20237:00 amRNSHolding(s) in Company
6th Nov 20237:00 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSHolding(s) in Company
31st Oct 20237:00 amRNSLicence Extension of Satu Mare Concession
23rd Oct 20237:00 amRNSHolding(s) in Company
22nd Sep 20237:00 amRNSDirector/PDMR Exercise of Options
4th Sep 20237:00 amRNSDirector/PDMR Shareholding
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
18th Aug 20234:12 pmRNSHolding(s) in Company
18th Aug 20237:00 amRNSDirector/PDMR Purchase of Shares
18th Aug 20237:00 amRNSHolding(s) in Company
18th Aug 20237:00 amRNSDirector/PDMR Purchase of Shares
17th Aug 20235:32 pmRNSReplacement - Holding(s) in Company
17th Aug 20237:00 amRNSHolding(s) in Company
17th Aug 20237:00 amRNSHolding(s) in Company
17th Aug 20237:00 amRNSHolding(s) in Company
16th Aug 20237:00 amRNSDirector/PDMR Purchase of Shares
14th Aug 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
7th Aug 20237:00 amRNSInvestor Presentation
5th Jun 20237:00 amRNSCompletion of Sabria N-2 Well Workover in Tunisia
2nd Jun 20233:53 pmRNSAward under Long-Term Incentive Plan
11th May 202311:55 amRNSVoting Results from AGM
11th May 20237:00 amRNSInterim Results for 3 months ended 31 March 2023
10th May 20235:22 pmRNSDirector Resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.